TFF Pharmaceuticals (TFFP)
(Delayed Data from NSDQ)
$2.21 USD
+0.17 (8.33%)
Updated May 24, 2024 03:59 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Brokerage Reports
TFF Pharmaceuticals, Inc. [TFFP]
Reports for Purchase
Showing records 141 - 149 ( 149 total )
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Enters CRADA with USAMRIID to Apply TFF Platform to Antibody and Vaccine
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Collaborates with University of Georgia to Pursue Universal Flu Vaccine
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Niclosamide Demonstrates Potential of Thin Film Freezing for COVID-19
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Many Business Development Irons in the Fire, TFF Vori in Phase 1 - 4Q19
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J